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Choking is a life-threatening and not infrequent occurrence in psychiatric hospitals. 
There is, however, little information available about the risk factors or methods to 
prevent choking. We conducted a retrospective analysis of the 8 patients who had a 
cardiopulmonary arrest due to choking and received resuscitation at our hospital   during 
the 6-year period from April 2005 to March 2011. The study involved 6 males and 
2 females, all of whom were patients with schizophrenia taking antipsychotics orally. 
They were aged from 56 to 79 (mean ± SD: 69.0 ± 7.5 years), with the   duration of 
  illness from 28 to 54 years (39.9 ± 7.9 years). In 6 of the 8 cases, choking was diagnosed 
immediately on the basis of the situation at the time of cardiopulmonary arrest. In the 
remaining 2 cases, cardiopulmonary arrest was initially unexplained, and choking was 
only diagnosed subsequently. Choking was caused by bread in all cases. Tracheal intu-
bation was carried out in all cases and resulted in successful resuscitation,   causing no 
subsequent change in functions compared with the prechoking condition. All 8 patients 
had been receiving multiple antipsychotics before the event (mean number of drugs used 
2.5 ± 0.7), with a total dose level ranging from 600 to 1800 mg/day chlorpromazine 
equivalents (mean 1113 ± 341 mg/day). Seven of the 8 patients had mild to moderate 
involuntary movements, and 5 patients were diagnosed with   antipsychotic-induced tar-
dive dyskinesia. During the 5-year period before the choking event, 7 of the 8 patients 
had at least 1 treatment interruption, and some patients had up to 4 interruptions. 
On average, patients had 2.3 interruptions (mean 2.3 ± 1.2 times) during the preceding 
5-year period. Anti-Parkinsonian drugs were used in 6 of the 8 patients with mean dose 
of 2.6 ± 1.7 mg/day (biperiden   equivalents). In 6 patients, hypnotic benzodiazepines had 
been prescribed at a mean dose of 10.6 ± 9.2 mg/day (diazepam equivalents).   Pharyngeal 
reflex was checked after recovery by depressing the lingual root with a tongue depressor 
and was found to be was absent in all cases. Six of the 8 patients had frequent abnormal 
eating behaviors (such as fast eating, hidden eating) before the event. Only 2 of the 8 
patients had a history of aspiration pneumonia.
The cases of choking in our study were characterized by a high proportion of 
male patients, long duration of illness, use of multiple antipsychotics, a history 
of interrupted antipsychotic use, locomotor disorders (extrapyramidal symptoms 
and tardive dyskinesia), loss of pharyngeal reflex and   abnormal eating behaviors. These 
characteristic are similar to those reported for a group of Chinese war veterans.1
A history of aspiration pneumonia did not predict   choking. Dysphagia induced by 
antipsychotics has been reported to increase the risk of both aspiration pneumonia and Neuropsychiatric Disease and Treatment
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choking.2 Aspiration pneumonia arises from microaspiration 
causing the entry of small amounts of food and oral indig-
enous microbial flora into the trachea. It is often attributable 
to silent aspiration, and a major mechanism for its onset is 
reduction in throat reflex mediated by   antipsychotic-induced 
decrease of substance P.3 It is not always accompanied by 
extrapyramidal symptoms. Respiratory arrest in cases of 
choking is not, however, caused by entry of food into the 
trachea but by obstruction of the pharynx with food mass.
Locomotor disorders such as tardive dyskinesia are major 
risk factors for choking, and the risk is higher if accompanied 
by abnormal eating behaviors.4 Locomotor disorders due 
to antipsychotics are more likely to occur with the use of 
multiple antipsychotics at high doses, exceeding the level 
required for optimal dopamine D2 receptor   blockade. In 
animal studies using antipsychotics, about 80% D2 recep-
tor blockade for 4 weeks resulted in upregulation of D2 
receptors, increasing the risk for tardive dyskinesia.5 Long-
term use of antipsychotics can also increase the risk for 
tardive dyskinesia mediated by D2 receptor upregulation. 
Interruption of antipsychotic use might thus be expected to 
reduce extrapyramidal symptoms. In practice, this appears 
not to be the case, since in our study, 7 of the 8 patients 
had experienced interruption of antipsychotic use before 
the event. Conversely, there are reports that interruption of 
antipsychotic treatment may increase the risk of extrapyra-
midal symptoms.6 In an animal study, intermittent treatment 
with antipsychotics was found to induce persistent vacuous 
chewing, suggestive of tardive dyskinesia.7 Extrapyramidal 
symptoms in animals also occurred more frequently when 
the degree of D2 blockade was rapidly increased by changes 
in blood antipsychotic drug levels8,9 To prevent choking, it 
is thus seems important to minimize locomotor disorders 
by optimizing the antipsychotic dose and avoiding sudden 
changes in D2 receptor blockade.
If a patient loses consciousness during a meal, it is easy 
to suspect a choking accident. However, if the event occurs 
during hidden eating an immediate diagnosis of choking is 
unlikely. Although food in the oral cavity would suggest chok-
ing, we had a case where respiratory arrest took place due 
to obstruction of the pharynx with food mass, with no food 
found in the oral cavity. Choking needs to be systematically 
considered as a possible cause of cardiopulmonary arrest in 
psychiatric inpatients.
Although choking is a severe complication in long-stay 
psychiatric inpatients, no major study has been conducted on 
this kind of event. A multicenter investigation into choking 
in psychiatric hospitals and guidelines for its prevention is 
clearly warranted.
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